{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:52:59Z","timestamp":1790077979878,"version":"4.0.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12664-011-0148-y","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T18:13:47Z","timestamp":1324318427000},"page":"245-254","source":"Crossref","is-referenced-by-count":12,"title":["Clostridium difficile infection: clinical spectrum and approach to management"],"prefix":"10.1007","volume":"30","author":[{"given":"Chetana","family":"Vaishnavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,20]]},"reference":[{"key":"148_CR1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","volume":"31","author":"SH Cohen","year":"2010","unstructured":"Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431\u201355.","journal-title":"Infect Control Hosp Epidemiol."},{"key":"148_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.gerinurse.2007.04.005","volume":"28","author":"NL Crogan","year":"2007","unstructured":"Crogan NL, Evans BC. Clostridium difficile: an emerging epidemic in nursing homes. Geriatr Nurs. 2007;28:161\u20134.","journal-title":"Geriatr Nurs."},{"key":"148_CR3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4065\/76.7.725","volume":"76","author":"SF Yassin","year":"2001","unstructured":"Yassin SF, Young-Fadok TM, Zein NN, Pardi DS. Clostridium difficile associated diarrhea and colitis. Mayo Clin Proc. 2001;76:725\u201330.","journal-title":"Mayo Clin Proc."},{"key":"148_CR4","first-page":"739","volume":"92","author":"R Fekety","year":"1997","unstructured":"Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 1997;92:739\u201350.","journal-title":"Am J Gastroenterol."},{"key":"148_CR5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/502603","volume":"26","author":"S Modena","year":"2005","unstructured":"Modena S, Bearelly D, Swartz K, Friedenberg FK. Clostridium difficile among hospitalized patients receiving antibiotics: a case\u2013control study. Infect Control Hosp Epidemiol. 2005;26:685\u201390.","journal-title":"Infect Control Hosp Epidemiol."},{"key":"148_CR6","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1086\/652648","volume":"50","author":"EL Best","year":"2010","unstructured":"Best EL, Fawley WN, Parnell P, Wilcox MH. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin Infect Dis. 2010;50:1450\u20137.","journal-title":"Clin Infect Dis."},{"key":"148_CR7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-135-6-200109180-00012","volume":"135","author":"S Johnson","year":"2001","unstructured":"Johnson S, Kent SA, O\u2019Leary KJ, et al. Fatal pseudomembranous colitis associated with a variant Clostridium difficile strain not detected by toxin A immunoassay. Ann Intern Med. 2001;135:434\u20138.","journal-title":"Ann Intern Med."},{"key":"148_CR8","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S1286-4579(00)01343-5","volume":"2","author":"C Vaishnavi","year":"2000","unstructured":"Vaishnavi C, Bhasin D, Kochhar R, Singh K. Clostridium difficile toxin and faecal lactoferrin assays in adult patients. Microbes Infect. 2000;2:1827\u201330.","journal-title":"Microbes Infect."},{"key":"148_CR9","first-page":"220","volume":"77","author":"FJ Tedesco","year":"1982","unstructured":"Tedesco FJ. Treatment of recurrent antibiotic-associated pseudomembranous colitis. Am J Gastroenterol. 1982;77:220\u20131.","journal-title":"Am J Gastroenterol."},{"key":"148_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0002-9343(85)90460-7","volume":"78","author":"RL Gebhard","year":"1985","unstructured":"Gebhard RL, Gerding DN, Olson MM, et al. Clinical and endoscopic findings in patients early in the course of Clostridium difficile-associated pseudomembranous colitis. Am J Med. 1985;78:45\u20138.","journal-title":"Am J Med."},{"key":"148_CR11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007611-199610000-00019","volume":"89","author":"SF Jafri","year":"1996","unstructured":"Jafri SF, Marshall JB. Ascites associated with antibiotic-associated pseudomembranous colitis. South Med J. 1996;89:1014\u20137.","journal-title":"South Med J."},{"key":"148_CR12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/MCC.0b013e3282638879","volume":"13","author":"SD Adams","year":"2007","unstructured":"Adams SD, Mercer DW. Fulminant Clostridium difficile colitis. Curr Opin Crit Care. 2007;13:450\u20135.","journal-title":"Curr Opin Crit Care."},{"key":"148_CR13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-81-4-429","volume":"81","author":"FJ Tedesco","year":"1974","unstructured":"Tedesco FJ, Barton RW, Alpers DH. Clindamycin associated colitis. A prospective study. Ann Intern Med. 1974;81:429\u201333.","journal-title":"Ann Intern Med."},{"key":"148_CR14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1056\/NEJM199907153410309","volume":"341","author":"L Laine","year":"1999","unstructured":"Laine L. Management of acute colonic pseudo-obstruction. N Engl J Med. 1999;341:192\u20133.","journal-title":"N Engl J Med."},{"key":"148_CR15","doi-asserted-by":"crossref","first-page":"S392","DOI":"10.14309\/00000434-200609001-00992","volume":"101","author":"LA Mahajan","year":"2006","unstructured":"Mahajan LA, Hupertz V, Mahajan S, et al. The appendix: a possible reservoir for Clostridium difficile. Am J Gastroenterol. 2006;101:S392.","journal-title":"Am J Gastroenterol."},{"key":"148_CR16","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","volume":"271","author":"LV McFarland","year":"1994","unstructured":"McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913\u20138.","journal-title":"JAMA."},{"key":"148_CR17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00004836-199301000-00008","volume":"16","author":"R Kochhar","year":"1993","unstructured":"Kochhar R, Ayyagiri A, Goenka MK, Dhali GK, Aggarwal R, Mehta SK. Role of infectious agents in exacerbation of ulcerative colitis in India: a study of Clostridium difficile. J Clin Gastroenterol. 1993;16:26\u201330.","journal-title":"J Clin Gastroenterol."},{"key":"148_CR18","first-page":"13","volume":"24","author":"C Vaishnavi","year":"2003","unstructured":"Vaishnavi C, Kochhar R, Bhasin DK, Thennarasu K, Singh K. Simultaneous assay for Clostridium difficile and fecal lactoferrin in ulcerative colitis. Trop Gastroenterol. 2003;24:13\u20136.","journal-title":"Trop Gastroenterol."},{"key":"148_CR19","first-page":"472","volume":"127","author":"R Balamurugan","year":"2008","unstructured":"Balamurugan R, Balaji V, Ramakrishna BS. Estimation of faecal carriage of Clostridium difficile in patients with ulcerative colitis using real time polymerase chain reaction. Indian J Med Res. 2008;127:472\u20137.","journal-title":"Indian J Med Res."},{"key":"148_CR20","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3748\/wjg.15.1554","volume":"15","author":"P Hookman","year":"2009","unstructured":"Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol. 2009;15:1554\u201380.","journal-title":"World J Gastroenterol."},{"key":"148_CR21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","volume":"103","author":"GC Nguyen","year":"2008","unstructured":"Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443\u201350.","journal-title":"Am J Gastroenterol."},{"key":"148_CR22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","volume":"5","author":"JF Rodemann","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, Seo da H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339\u201344.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"148_CR23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.24.8.713","volume":"24","author":"C Greenfield","year":"1983","unstructured":"Greenfield C, Aguilar Ramirez JR, Pounder RE, et al. Clostridium difficile and inflammatory bowel disease. Gut. 1983;24:713\u20137.","journal-title":"Gut"},{"key":"148_CR24","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/ibd.20500","volume":"14","author":"M Issa","year":"2008","unstructured":"Issa M, Ananthakrishnan AN. Clostridium difficile and inflammatory bowel disease. Inflam Bowel Dis. 2008;14:1432\u201342.","journal-title":"Inflam Bowel Dis."},{"key":"148_CR25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00005176-199107000-00007","volume":"13","author":"JD Gryboski","year":"1991","unstructured":"Gryboski JD. Clostridium difficile in inflammatory bowel disease relapse. J Pediatr Gastroenterol Nutr. 1991;13:39\u201341.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"148_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/985658","volume":"2008","author":"E Boland","year":"2009","unstructured":"Boland E, Thompson JS. Fulminant Clostridium difficile enteritis after proctocolectomy and ileal pouch\u2013anal anastomosis. Gastroenterol Res Pract. 2009;2008:1\u20135.","journal-title":"Gastroenterol Res Pract."},{"key":"148_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1757-4749-1-7","volume":"1","author":"U Navaneethan","year":"2009","unstructured":"Navaneethan U, Giannella RA. Thinking beyond the colon\u2014small bowel involvement in Clostridium difficile infection. Gut Pathog. 2009;1:7.","journal-title":"Gut Pathog."},{"key":"148_CR28","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/313825","volume":"30","author":"A Bhargava","year":"2000","unstructured":"Bhargava A, Sen P, Swaminathan A, Ogbolu C, Chechko S, Stone F. Rapidly progressive necrotizing fasciitis and gangrene due to Clostridium difficile. Clin Infect Dis. 2000;30:954\u20135.","journal-title":"Clin Infect Dis."},{"key":"148_CR29","doi-asserted-by":"crossref","unstructured":"Libby DB, Bearman G. Bacteremia due to Clostridium difficile\u2014review of the literature. Int J Infect Dis. 2009:13: e305\u20139. Epub.","DOI":"10.1016\/j.ijid.2009.01.014"},{"key":"148_CR30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/014107688007300714","volume":"73","author":"SD Fairweather","year":"1980","unstructured":"Fairweather SD, Youngs D, George RH, Burdon DW, Keighley MR. Arthritis in pseudomembranous colitis associated with an antibody to Clostridium difficile toxin. J R Soc Med. 1980;73:524\u20135.","journal-title":"J R Soc Med."},{"key":"148_CR31","first-page":"171","volume":"160","author":"JL Boice","year":"1994","unstructured":"Boice JL. Reactive arthritis induced by Clostridium difficile. West J Med. 1994;160:171\u20132.","journal-title":"West J Med."},{"key":"148_CR32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10067-007-0710-2","volume":"27","author":"J Birnbaum","year":"2008","unstructured":"Birnbaum J, Bartlett JG, Gelber AC. Clostridium difficile: an under recognized cause of reactive arthritis? Clin Rheumatol. 2008;27:253\u20135.","journal-title":"Clin Rheumatol."},{"key":"148_CR33","doi-asserted-by":"crossref","unstructured":"Jacobs A, Barnard K, Fishel R, Gradon JD. Extracolonic manifestations of Clostridium difficile infections. Presentation of 2 cases and review of the literature. Medicine (Baltimore). 2001:80:88\u2013101.","DOI":"10.1097\/00005792-200103000-00002"},{"key":"148_CR34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.medmal.2005.04.003","volume":"35","author":"S Ducroix-Roubertou","year":"2005","unstructured":"Ducroix-Roubertou S, Genet C, Rogez JP, Weinbreck P, Denes E. Reactive arthritis due to Clostridium difficile. Med Mal Infect. 2005;35:419\u201321.","journal-title":"Med Mal Infect."},{"key":"148_CR35","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cgh.2007.04.016","volume":"5","author":"TA Brown","year":"2007","unstructured":"Brown TA, Rajappannair L, Dalton AB, Bandi R, Myers JP, Kefalas CH. Acute appendicitis in the setting of Clostridium difficile colitis: case report and review of the literature. Clin Gastroenterol Hepatol. 2007;5:969\u201371.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"148_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.30.1.1","volume":"30","author":"AB Price","year":"1977","unstructured":"Price AB, Davies DR. Pseudomembranous colitis. J Clin Pathol. 1977;30:1\u201312.","journal-title":"J Clin Pathol."},{"key":"148_CR37","first-page":"211","volume":"107","author":"SJ Schnitt","year":"1983","unstructured":"Schnitt SJ, Antonioli DA, Goldman H. Massive mural edema in severe pseudomembranous colitis. Arch Pathol Lab Med. 1983;107:211\u20133.","journal-title":"Arch Pathol Lab Med."},{"key":"148_CR38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0255-0857.55436","volume":"27","author":"C Vaishnavi","year":"2009","unstructured":"Vaishnavi C. Established and potential risk factors for Clostridium difficile infection. Indian J Med Microbiol. 2009;27:289\u2013300.","journal-title":"Indian J Med Microbiol."},{"key":"148_CR39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1399-3062.2004.00040.x","volume":"6","author":"K Keven","year":"2004","unstructured":"Keven K, Basu A, Re L. Clostridium difficile colitis in patients after kidney and pancreas\u2013kidney transplantation. Transpl Infect Dis. 2004;6:10\u20134.","journal-title":"Transpl Infect Dis."},{"key":"148_CR40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0195-6701(03)00088-4","volume":"54","author":"R Cunningham","year":"2003","unstructured":"Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54:243\u20135.","journal-title":"J Hosp Infect."},{"key":"148_CR41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1399-3062.2007.00255.x","volume":"9","author":"ZF Gellad","year":"2007","unstructured":"Gellad ZF, Alexander BD, Liu JK, et al. Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. Transpl Infect Dis. 2007;9:276\u201380.","journal-title":"Transpl Infect Dis."},{"key":"148_CR42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/sur.2006.062","volume":"8","author":"M Zerey","year":"2007","unstructured":"Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt). 2007;8:557\u201366.","journal-title":"Surg Infect (Larchmt)."},{"key":"148_CR43","unstructured":"Weiss B, Kleinkauf N, Neumann M, et al. Risk factors for Clostridium difficile ribotype 027 infection in Germany: preliminary results of a retrospective case\u2013control study (abstract). 18th European Congress of Clin. Microbial and Infectious Diseases, Barcelona, Spain. 2008:1480."},{"key":"148_CR44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(05)70215-2","volume":"5","author":"S Aslam","year":"2005","unstructured":"Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease:old therapies and new strategies. Lancet Infect Dis. 2005;5:549\u201357.","journal-title":"Lancet Infect Dis."},{"key":"148_CR45","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J Pepin","year":"2005","unstructured":"Pepin J, Saheb N, Coulombe M, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhoea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41:1254\u201360.","journal-title":"Clin Infect Dis."},{"key":"148_CR46","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1128\/JCM.00224-07","volume":"45","author":"K Keel","year":"2007","unstructured":"Keel K, Brazier JS, Post KW, Weese S, Songer JG. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol. 2007;45:1963\u20134.","journal-title":"J Clin Microbiol."},{"key":"148_CR47","first-page":"398","volume":"82","author":"U Gupta","year":"1985","unstructured":"Gupta U, Jadav RN. Clostridium difficile in hospital patients. Indian J Med Res. 1985;82:398\u2013401.","journal-title":"Indian J Med Res."},{"key":"148_CR48","first-page":"157","volume":"4","author":"A Ayyagari","year":"1986","unstructured":"Ayyagari A, Sharma P, Venkateswarlu, Mehta S, Agarwal KC. Prevalence of Clostridium difficile in pseudomembranous and antibiotic associated colitis in North India. J Diarrhoeal Dis Res. 1986;4:157\u201360.","journal-title":"J Diarrhoeal Dis Res."},{"key":"148_CR49","first-page":"1129","volume":"28","author":"SK Niyogi","year":"1991","unstructured":"Niyogi SK, Dutta P, Dutta D, Mitra U, Sikdar S. Clostridium difficile and its cytotoxin in hospitalized children with acute diarrhea. Indian Pediatr. 1991;28:1129\u201332.","journal-title":"Indian Pediatr."},{"key":"148_CR50","first-page":"16","volume":"9","author":"SK Niyogi","year":"1991","unstructured":"Niyogi SK, Bhattacharya SK, Dutta P, et al. Prevalence of Clostridium difficile in hospitalised patients with acute diarrhoea in Calcutta. J Diarrhoeal Dis Res. 1991;9:16\u20139.","journal-title":"J Diarrhoeal Dis Res."},{"key":"148_CR51","first-page":"683","volume":"39","author":"MK Bhattacharya","year":"1991","unstructured":"Bhattacharya MK, Niyogi SK, Rasaily R, et al. Clinical manifestation of Clostridium difficile enteritis in Calcutta. J Assoc Physicians India. 1991;39:683\u20134.","journal-title":"J Assoc Physicians India."},{"key":"148_CR52","first-page":"33","volume":"20","author":"C Vaishnavi","year":"1999","unstructured":"Vaishnavi C, Kochhar R, Bhasin DK, Thapa BR, Singh K. Detection of Clostridium difficile toxin by an indigenously developed latex agglutination assay. Trop Gastroenterol. 1999;20:33\u20135.","journal-title":"Trop Gastroenterol."},{"key":"148_CR53","first-page":"81","volume":"16","author":"C Vaishnavi","year":"1998","unstructured":"Vaishnavi C, Kochhar R, Bhasin DK, et al. Faecal lactoferrin latex agglutination assay for Clostridium difficile associated intestinal disease. Indian J Med Microbiol. 1998;16:81\u20133.","journal-title":"Indian J Med Microbiol."},{"key":"148_CR54","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00007890-200204270-00010","volume":"73","author":"G Kang","year":"2002","unstructured":"Kang G, Srivastava A, Pulimood AB, Dennison D, Chandy M. Etiology of diarrhea in patients undergoing allogenic bone marrow transplantation in South India. Transplantation. 2002;73:1247\u201351.","journal-title":"Transplantation."},{"key":"148_CR55","first-page":"164","volume":"25","author":"B Kumar","year":"2004","unstructured":"Kumar B, Vaishnavi C, Sandhu K, Kaur I. Clostridium difficile toxin assay in psoriatic patients. Trop Gastroenterol. 2004;25:164\u20137.","journal-title":"Trop Gastroenterol."},{"key":"148_CR56","first-page":"518","volume":"122","author":"A Gogate","year":"2005","unstructured":"Gogate A, De A, Nanivadekar R, et al. Diagnostic role of stool culture and toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res. 2005;122:518\u201324.","journal-title":"Indian J Med Res."},{"key":"148_CR57","first-page":"377","volume":"127","author":"R Chaudhry","year":"2008","unstructured":"Chaudhry R, Joshy L, Kumar L, Dhawan B. Changing pattern of Clostridium difficile associated diarrhoea in a tertiary care hospital: a 5\u00a0year retrospective study. Indian J Med Res. 2008;127:377\u201382.","journal-title":"Indian J Med Res."},{"key":"148_CR58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12664-011-0097-5","volume":"30","author":"M Ingle","year":"2011","unstructured":"Ingle M, Deshmukh A, Desai D, et al. Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis. Indian J Gastroenterol. 2011;30:89\u201393.","journal-title":"Indian J Gastroenterol."},{"key":"148_CR59","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(83)91036-X","volume":"2","author":"PG Teasley","year":"1983","unstructured":"Teasley PG, Gerding DN, Olson MM, et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet. 1983;2:1043\u20136.","journal-title":"Lancet."},{"key":"148_CR60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/QCO.0b013e32833229ce","volume":"22","author":"MP Bauer","year":"2009","unstructured":"Bauer MP, van Dissel JT, Kuijper EJ. Clostridium difficile: controversies and approaches to management. Curr Opin Infect Dis. 2009;22:517\u201324.","journal-title":"Curr Opin Infect Dis."},{"key":"148_CR61","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cgh.2009.05.031","volume":"7","author":"S Ben-Horin","year":"2009","unstructured":"Ben-Horin S, Margalit M, Bossuyt P, et al. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin Gastroenterol Hepatol. 2009;7:981\u20137.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"148_CR62","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/497832","volume":"41","author":"A Enache-Angoulvant","year":"2005","unstructured":"Enache-Angoulvant A, Hemnnequin C. Invasive Saccharmyces infection: a comprehensive review. Clin Infect Dis. 2005;41:1559\u201368.","journal-title":"Clin Infect Dis."},{"key":"148_CR63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gtc.2007.03.001","volume":"36","author":"J Park","year":"2007","unstructured":"Park J, Floch MH. Prebiotics, probiotics and dietary fiber in gastrointestinal diseases. Gastroenterol Clin North Am. 2007;36:47\u201363.","journal-title":"Gastroenterol Clin North Am."},{"key":"148_CR64","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1542-3565(04)00677-9","volume":"3","author":"S Lewis","year":"2005","unstructured":"Lewis S, Burmeister S, Brazier J. Effect of prebiotic oligofructose on relapse of Clostridium difficile associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol. 2005;3:442\u20138.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"148_CR65","first-page":"3603","volume":"103","author":"C Jorup-Ronstrom","year":"2006","unstructured":"Jorup-Ronstrom C, Hakonson A, Persson AK, Midtvedt T, Norin E. Feces culture successful therapy in Clostridium difficile diarrhea. Lakartidningen (Swedish). 2006;103:3603\u20135.","journal-title":"Lakartidningen (Swedish)."},{"key":"148_CR66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1086\/506349","volume":"43","author":"RJ Louie","year":"2006","unstructured":"Louie RJ, Peppe J, Watt CK, et al. Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile associated diarrhea. Clin Infect Dis. 2006;43:411\u201320.","journal-title":"Clin Infect Dis."},{"key":"148_CR67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.coph.2007.05.007","volume":"7","author":"A Balagopal","year":"2007","unstructured":"Balagopal A, Sears CL. Clostridium difficile: new therapeutic options. Curr Opin Pharmacol. 2007;7:455\u20138.","journal-title":"Curr Opin Pharmacol."},{"key":"148_CR68","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3476(05)83393-1","volume":"118","author":"DY Leung","year":"1991","unstructured":"Leung DY, Kelly CP, Bogunlewicz M, Pothoulakis C, LaMont JT, Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr. 1991;118:633\u20137.","journal-title":"J Pediatr."},{"key":"148_CR69","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/jhm.542","volume":"5","author":"MS Abougergi","year":"2010","unstructured":"Abougergi MS, Broor A, Cui W, Jaar BG. Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature. J Hospital Med. 2010;5:E1\u20139.","journal-title":"J Hospital Med."},{"key":"148_CR70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","volume":"362","author":"I Lowy","year":"2010","unstructured":"Lowy I, Molrine DC, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362:197\u2013205.","journal-title":"N Engl J Med."},{"key":"148_CR71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/jmm.0.45773-0","volume":"54","author":"JT Dissel van","year":"2005","unstructured":"van Dissel JT, Groot ND, Hensgens MH, et al. Bovine antibody enriched whey to aid in the prevention of a relapse of Clostridium difficile associated diarrhea: preclinical and preliminary clinical data. J Med Microbiol. 2005;54:197\u2013205.","journal-title":"J Med Microbiol."},{"key":"148_CR72","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/IAI.71.3.1608-1610.2003","volume":"71","author":"S Aboudala","year":"2003","unstructured":"Aboudala S, Kotloff KL, Kyne L, et al. Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Infect Immun. 2003;71:1608\u201310.","journal-title":"Infect Immun."},{"key":"148_CR73","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","volume":"128","author":"S Souigioltzis","year":"2005","unstructured":"Souigioltzis S, Kyne L, Drudy D, et al. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology. 2005;128:764\u201370.","journal-title":"Gastroenterology"},{"key":"148_CR74","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/506351","volume":"43","author":"DM Musher","year":"2006","unstructured":"Musher DM, Logan N, Hamill RJ, et al. Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis. 2006;43:421\u20137.","journal-title":"Clin Infect Dis."},{"key":"148_CR75","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/599224","volume":"48","author":"BL Herpers","year":"2009","unstructured":"Herpers BL, Vlaminckx B, Burkhardt O, et al. Intravenous tigecycline as adjunctive or alternate therapy for severe refractory Clostridium difficile infection. Clin Infect Dis. 2009;48:1732\u20135.","journal-title":"Clin Infect Dis."},{"key":"148_CR76","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","volume":"364","author":"TJ Louie","year":"2011","unstructured":"Louie TJ, Miller MA, Mullane KM. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422\u201331.","journal-title":"N Engl J Med."}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-011-0148-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-011-0148-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-011-0148-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:21:07Z","timestamp":1593390067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-011-0148-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["148"],"URL":"https:\/\/doi.org\/10.1007\/s12664-011-0148-y","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}